TURN YOUR IDEA INTO A FULLY- FUNDED CLINICAL TRIAL

IF YOU HAVE AN IDEA FOR AN INVESTIGATOR-INITIATED CLINICAL STUDY, MEDSIR CAN OFFER YOU A CROSS-FUNCTIONAL SYSTEM FULLY INTEGRATING THE STRATEGIC, SCIENTIFIC, AND OPERATIONAL ASPECTS OF INDEPENDENT CLINICAL RESEARCH.

WE WANT TO HELP YOU TURN YOUR INITIAL CONCEPT INTO A FULLY-FUNDED CLINICAL TRIAL!

The five ingredients for a successful IIT

icono-pdf.png

YOUR IDEA, OUR ENDEAVOR

home_fondo_tolife_barra.jpg
Screenshot 2020-04-17 at 13.55.12 2.png

 
WE PROTECT & SECURE YOUR IDEA

Your idea is, and will always be, yours and yours alone.

Screenshot 2020-04-17 at 13.55.12 3.png

WE CONVERT YOUR IDEA INTO A STRATEGIC
CLINICAL TRIAL


Our experience in clinical trials and market intelligence will help you design a full trial protocol that makes sense for patients, science, and companies.

Screenshot 2020-04-17 at 13.55.12.png

 
WE NEGOTIATE
YOUR TRIAL


Our business development team will confidentially present your idea to potential funders, searching for a win-win synergy.

Screenshot 2020-04-17 at 13.55.18.png

 
WE INVITE YOU ON BOARD AS CAPTAIN

You will lead the process from study start-up all the way through to the publication of study results.

MEDSIR CAN BE OF INTEREST FOR YOU IF...

home_fondo_tolife_barra.jpg

You are a clinical investigator in oncology with a concept for a novel trial and you would like to benefit, from a full support structure able to help you through all stages of development of your idea, free from any cost, (statistical design, medical writing, budget creation, securing of the funding, regulatory and operational management, etc.) while protecting your intellectual property at all times.

WHAT WE DO FOR CLINICAL INVESTIGATORS

home_fondo_tolife_barra.jpg
fundo_naranja-.png

1

Sharing your idea with us

  • Guaranteed confidentiality

  • We analyze the Strategic potential of the idea

  • Our KOL network can strengthen YOUR idea

iconos_investigators-1.png
flecha.png
fundo_naranja-.png

Synopsis development

  • Generation of solid rationale

  • Addition of statistical assumptions

  • Selection of best potential partners

  • We propose relevant translational research

  • You approve the final synopsis

flecha.png
iconos_investigators-2.png

2

fundo_naranja-.png

Secure funding

  • We pitch the proposal to industry partners

  • We build operational plan and budget

  • We negotiate the proposal

  • We present the idea to other companies, if needed

  • You approve all relevant decisions

flecha.png
iconos_investigators-3.png

3

fundo_naranja-.png

Trial Set up and Clinical trial Management

  • Full protocol writing

  • We assume the role of Sponsor

  • We coordinate your publications and presentations

  • You keep publication rights and access to all data

  • Any potential financial benefits will be shared

flecha.png
iconos_investigators-4.png

4

fundo_naranja-.png
  • We generate additional hypothesis to test in subsequent studies

iconos_investigators-5.png

Further study opportunities

flecha.png

5

START OF PROPOSAL DEVELOPMENT

SYNOPSIS APPROVAL

FUNDING ESTABLISHED 

FINAL RESULTS PUBLISHED

4180311.jpg

MEDSIR HELPS YOU CONVERT YOUR RESEARCH IDEA INTO A BRIGHTER FUTURE FOR CANCER PATIENTS

SOME OF OUR STUDIES

home_fondo_tolife_barra.jpg
3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

PHERGAIN

BREAST

Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: A FDG-PET response-adapted strategy

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

SLLIP

LUNG

Spanish Lung Liquid vs. Invasive biopsy Program (SLLIP)

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

ORPHEUS

PENIS

Phase II Study of the Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

PARSIFAL

BREAST

Palbociclib with fulvestrant or letrozole for HER-, ER+ metastatic breast cancer

SOME CLINICAL EXPERTS COLLABORATING WITH MEDSIR

home_fondo_tolife_barra.jpg
Peter Schmid

PETER SCHMID

Medical Oncologis MD, PhD

Joan Maurel

JORDI 

REMON

Medical Oncologist 
MD, PhD

Joseph Gligorov

JOSEPH GLIGOROV

Medical Oncologist 
MD, PhD

Noemí Reguart

NOEMÍ REGUART

Medical Oncologist 
MD, PhD

Andrés Poveda

PETER

KAUFMAN

Medical Oncologist 
MD, PhD

Joan Carles

JOAN CARLES

Medical Oncologist 
MD, PhD

José Pérez

JOSÉ PÉREZ

Medical Oncologist 
MD, PhD

Javier Garde

JAVIER GARDE

Medical Oncologist 
MD, PhD

Antonio Calles

ANTONIO

CALLES

Medical Oncologist MD, PhD

Niki Karachaliou

NIKI KARACHALIOU

Medical Oncologist 
MD, PhD

Josep Maria Piulats

JOSEP MARIA

PIULATS

Medical Oncologist 
MD, PhD

Esther Holgado

MARINA GARASSINO

Medical Oncologist 
MD, PhD

Frederik Marmé

FREDERIK MARMÉ

Gynecologist 
MD, PhD

Ignacio Romero

EDWARD

GARON

Medical Oncologist 
MD, PhD

José Enrique Alés

ANTONIO

LLOMBART

Medical Oncologist 
MD, PhD

Elena Aguirre

JAVIER

CORTÉS

Medical Oncologist 
MD, PhD

FREQUENTLY ASKED QUESTIONS

home_fondo_tolife_barra.jpg
84803.jpg

TURN YOUR IDEA INTO A FULLY FUNDED CLINICAL TRIAL

COLLABORATE WITH MEDSIR ON THE DEVELOPMENT OF YOUR IDEA IN ORDER TO FIND THE NEXT GROUNDBREAKING THERAPY ABLE TO IMPROVE THE LIVES OF CANCER PATIENTS WORLDWIDE.

Ready to turn your idea into reality?

If you have an idea for an investigator-initiated clinical trial and would like to take advantage of our support structure to fully develop it, fill in the form below and get in touch with us!

We are here to support you!

arrow&v